Adjuvant Target Therapy Guided by ctDNA-MRD in Patients With EGFR-mutant II-IIIA Non-small Cell Lung Cancer (ECTOP-1022)

Clinical trial NCT06323148 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06323148
Sponsor: Fudan University
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Lung Cancer EGFR Gene Mutation Minimal Residual Disease

Start date: 2024-04-01
Primary completion: 2026-03-31
Enrollment: 226

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.